Home/Hedge Fund Intelligence/PFM Healthcare Master Fund
Hedge FundCayman IslandsMaster fund3(c)(7) · qualified purchasers

PFM Healthcare Master Fund

Estimated returns, assets and SEC record

Managed by PFM Health Sciences, LP · San Francisco · in Form ADV since 2013 Also runs 2 other funds we cover

PFM Healthcare Master Fund is a Cayman Islands hedge fund managed by PFM Health Sciences, LP. It reported gross assets of USD 2.2bn in the Form ADV filed 24 June 2024. Hedge funds do not file their returns with the SEC. From what this fund and its manager do file, PPLI Vortex estimates that it returned about 16.0% in 2025, with a likely range of 3.4% to 38.6%.

Unqualified audit opinionIndependent administratorPCAOB-registered auditor
2025, estimated+16.0%range 3.4% to 38.6% · grade D-est
Three years, a year+3.0%2023 to 2025, compounded from the yearly estimates and their ranges
Latest quarter+13.0%to 30 Jun 2026 · range 6.0% to 20.0%
Gross assetsUSD 2.2bnForm ADV · filed 24 Jun 2024
Investors425beneficial owners
In SEC filings since2013first Form ADV listing

Compiled by PPLI Vortex from SEC filings · Hedge Fund Intelligence, PPLI.com · updated · about PPLI Vortex

Return figures are PPLI.com estimates from public SEC filings, not numbers reported by the fund. Not investment advice. Important information

PPLI.com
Hedge Fund Rating
Rating in preparation
We publish a rating only once a fund's file has been through editorial review. This fund is in the queue.
Returns
Risk
SEC record and governance
Fees and terms
Fit for a PPLI policy
Editorial assessment from SEC filings
Reviewed every quarter
About the rating
D
Confidence grade D-est

One registered fund holds this fund. We infer the return from the change in the value it reports.

How the grades work

A and B are computed from public filings. C, C-est and D-est are estimates built on what registered funds that hold the fund report. D-13F is an estimate from the manager's 13F long book. Every figure on this page is shown with its range and grade.

Quarter by quarter

PFM Healthcare Master Fund, one quarter at a time

How the estimate moved through each year since 2021, with the yearly figure alongside.

Each cell is our estimate for that quarter, with the range it could fall in underneath. The last column is the figure for the full year. It is worked out on its own from the year's filings, so the four quarters will not multiply out to it exactly. Every figure here is graded D-13F and D-est.

YearJan to MarApr to JunJul to SepOct to DecFull year
20260.0%-7.9% to 5.8%+13.0%6.0% to 20.0%not yet filednot yet filed+11.4%-2.3% to 25.1%, to 30 Jun
2025+1.2%-5.6% to 10.0%+2.7%-5.6% to 9.8%+3.0%-5.6% to 11.4%+5.9%-5.7% to 17.1%+16.0%3.4% to 38.6%
2024+6.9%-18.3% to 13.7%−3.1%-20.3% to 5.1%−2.2%-23.3% to 9.9%−13.2%-27.5% to 3.0%−15.5%-35.8% to 17.4%
2023−1.6%-8.4% to 5.3%+5.2%-16.5% to 12.8%0.0%-18.2% to 6.2%+5.2%-30.0% to 15.0%+11.4%-4.5% to 22.9%
2022−1.8%-10.4% to 5.0%−2.7%-12.2% to 5.0%+1.0%-5.0% to 8.9%+1.9%-5.0% to 10.6%0.0%computed
2021+1.0%-5.0% to 8.8%+1.8%-5.0% to 10.5%+1.3%-5.0% to 9.5%+0.8%-5.3% to 8.4%0.0%computed

Estimates by PPLI Vortex from public SEC filings, not figures reported by the fund. n/a means the filings do not support a figure for that quarter.

Next: what the manager holds
Holdings

98 positions, with 34% of the money in the ten largest

PFM Healthcare Master Fund does not publish what it owns. Its manager does: every quarter PFM Health Sciences, LP lists its U.S.-listed stocks and options on Form 13F. The list covers every account the firm runs, not this fund alone, and leaves out short positions, bonds, swaps and shares listed outside the United States. Most of what the firm's hedge funds hold is in this book, so it is a fair picture of the fund.

Value reportedUSD 1.2bn
Positions98
In the ten largest34%
Largest positionAscendis Pharma A/S, 5.3%
Call options, underlying valueUSD 1
Put options, underlying valueUSD 1
Holdings as of30 June 2026
The 15 largest positions

Share is of the total value reported. Options are shown at the value of the shares they cover. Choose a company to see which other managers report it.

#CompanyValueShare of the book
1 Nasdaq: ASNDShsHeld by 36 of the 720 managers we trackUSD 62m5.3%
2 Nasdaq: AXSMHeld by 56 of the 720 managers we trackUSD 54m4.6%
3 NYSE: LLYHeld by 106 of the 720 managers we trackUSD 47m4.0%
4 Nasdaq: JAZZUsdHeld by 31 of the 720 managers we trackUSD 39m3.3%
5 NYSE: HUMHeld by 50 of the 720 managers we trackUSD 37m3.2%
6 NYSE: UNHHeld by 107 of the 720 managers we trackUSD 37m3.1%
7 Nasdaq: NBIXHeld by 35 of the 720 managers we trackUSD 36m3.1%
8 Nasdaq: INBXHeld by 27 of the 720 managers we trackUSD 29m2.5%
9 Nasdaq: UTHRHeld by 57 of the 720 managers we trackUSD 27m2.3%
10 Nasdaq: RVMDHeld by 69 of the 720 managers we trackUSD 27m2.3%
11 Nasdaq: ICLRHeld by 31 of the 720 managers we trackUSD 24m2.0%
12 NYSE: THCNewHeld by 42 of the 720 managers we trackUSD 24m2.0%
13 NYSE: EWHeld by 44 of the 720 managers we trackUSD 23m1.9%
14 NYSE: WATHeld by 47 of the 720 managers we trackUSD 22m1.9%
15 NYSE: PENHeld by 54 of the 720 managers we trackUSD 19m1.6%
Ascendis Pharma A/S: 5.3%Axsome Therapeutics, Inc.: 4.6%ELI LILLY & Co: 4.0%Jazz Pharmaceuticals plc: 3.3%Humana Inc: 3.2%Unitedhealth Group Inc: 3.1%Neurocrine Biosciences Inc: 3.1%Inhibrx Biosciences, Inc.: 2.5%Positions 9 to 15: 14.2%The rest of the book: 56.5%98POSITIONS
How the book is split
  • Ascendis Pharma A/S5.3%
  • Axsome Therapeutics, Inc.4.6%
  • ELI LILLY & Co4.0%
  • Jazz Pharmaceuticals plc3.3%
  • Humana Inc3.2%
  • Unitedhealth Group Inc3.1%
  • Neurocrine Biosciences Inc3.1%
  • Inhibrx Biosciences, Inc.2.5%
  • Positions 9 to 1514.2%
  • The rest of the book56.5%
Next: the manager's other funds
The manager's funds

PFM Health Sciences, LP runs 3 funds we cover

Every fund of PFM Health Sciences, LP on PPLI.com

3 funds, largest first by gross assets. Returns are PPLI Vortex estimates; each has its own range on that fund's page. Figures graded D-13F are one estimate made for the manager as a whole and shown on each of its funds, so they are not separate readings and should not be compared with one another.

FundSinceGross assetsStrategy202120222023202420252026part year
PFM Healthcare Master Fundthis page2013first SEC listingUSD 2.2bnHealthcarefrom the fund's name0.0%0.0%+11.4%−15.5%+16.0%+11.4%
Partner InvestmentsUnited States2014first SEC listingUSD 24mHealthcare and biotechnologywhat the manager says it does+11.0%−3.2%+9.2%+3.7%+22.7%+11.4%
PFM Liquidating Sidepocket FundUnited States2012 or earlierfirst SEC listingUSD 467,000Healthcare and biotechnologywhat the manager says it does+11.0%−3.2%+9.2%+3.7%+22.7%+11.4%

The 2026 column covers the part of the year the filings reach so far; the fund's own page gives the end date. SEC filings do not state a strategy for each fund. The column shows what the fund's own name says, or failing that how the manager describes itself, and says which. A year of formation is shown where a Form D gives one; otherwise it is the year the fund first appears in the SEC's Form ADV data.

Next: returns year by year
Returns year by year

About 16% in 2025, with a range too wide to call against the index

The SEC filings of PFM Healthcare Master Fund carry no return figures. These are our estimates, each with the range we think the true figure falls in and a grade for how it was reached.

Gold bars are the fund. The thin line on each bar is the range we think the true figure falls in. Grey bars are the S&P 500 total return in U.S. dollars, dividends reinvested, over the same calendar years. It is there as a picture of the market, not as the benchmark this fund sets itself.

-40%-20%0%20%40%20210.0%20220.0%202311.4%2024-15.5%202516.0%2026 to date11.4%
PeriodReturnLikely rangeGradeS&P 500Difference
20210.0%computed, no rangeB28.7%-28.7 pts
20220.0%computed, no rangeB-18.1%+18.1 pts
202311.4%-4.5% to 22.9%D-est26.3%-14.8 pts
2024-15.5%-35.8% to 17.4%D-est25.0%-40.6 pts
202516.0%3.4% to 38.6%D-est17.9%-1.8 pts
2026 to 30 Jun11.4%-2.3% to 25.1%D-13F

Returns are before the fees an investor pays unless they come from a public holder's reported value, which is after the fund's own fees.

USD 100 in PFM Healthcare Master Fund against the S&P 500start of 2021 = 100

The gold line compounds our yearly figures. The shaded area is where the line would run if every year came in at the low or the high end of its range. The grey line is the S&P 500 with dividends.

100150200StartEnd 2021End 2022End 2023End 2024End 2025Fund 109S&P 500 196

By the end of 2025, USD 100 in the fund had become about USD 109 by our estimate, against USD 196 in the index.

What an investor would have kept, 2021 to 2025

Takes our yearly figures for PFM Healthcare Master Fund and shows what is left after fees and tax, next to the same money inside a PPLI policy. Change any of the numbers. These figures already reflect the fund's own fees.

PFM Healthcare Master Fund, as estimatedour yearly figures compounded, before taxUSD 1.1m
After tax, held directlygains taxed every year at the rate you enteredUSD 1m
Held inside a PPLI policyno yearly tax on gains inside a policy that keeps to the rules, less the yearly policy costUSD 1m
S&P 500 with dividendsthe index over the same years, before taxUSD 2m
Each year: as estimated, after fees, after tax and inside a policy
YearAs estimatedAfter feesAfter taxInside a policyS&P 500
20210.0%0.0%0.0%-1.0%28.7%
20220.0%0.0%0.0%-1.0%-18.1%
202311.4%11.4%6.8%10.3%26.3%
2024-15.5%-15.5%-15.5%-16.4%25.0%
202516.0%16.0%16.0%14.9%17.9%

The tax rate of 40.8% is the top U.S. federal rate on short-term gains with the net investment income tax; a fund whose gains are mostly long-term would be taxed at 23.8%. State tax is not included. Policy costs differ by carrier and by the size of the policy. If every year had come in at the bottom or the top of our range, the first line would read USD 634,000 or USD 2m. An illustration, not advice.

The record in numbers

Worked out from the yearly figures above, 2021 to 2025. They carry the same ranges and grades.

Annualised return1.8%
Best year16.0% in 2025
Worst year-15.5% in 2024
Years ahead of the S&P 5001 of 5
Total over the period9.2%
S&P 500 over the period96.2%
Losing years2 of 5
Average width of our range23 points
Returns by period

Annualised where the period is longer than a year. The range compounds the low and high ends of each year.

PeriodPFM Healthcare Master FundLikely rangeS&P 500Difference
Latest year202516.0%3.4% to 38.6%17.9%-1.8 pts
Three years, a year2023 to 20253.0%-14.1% to 26.0%23.0%-20.0 pts
Five years, a year2021 to 20251.8%-8.7% to 14.9%14.4%-12.6 pts
Risk, as far as yearly figures show it

Measured at year ends only. A fall and recovery inside a single year does not appear here.

Deepest fall between year ends-15.5%
Reached at the end of2024
S&P 500, same measure-18.1%
Losing years2 of 5
2022, side by side
PFM Healthcare Master Fund0.0%range computed, no range
S&P 500-18.1%with dividends

2022 was the one year in this period when the index fell. By our estimate the fund lost less than the index.

Compare with other funds

Type the name of any fund we estimate and it joins the table. Up to five at a time. Every figure is an estimate; open a fund to see its range and grade.

Fund20212022202320242025
PFM Healthcare Master Fund0.0%0.0%11.4%-15.5%16.0%
S&P 500 with dividends28.7%-18.1%26.3%25.0%17.9%

Over 2023 to 2025 the estimates compound to 9.2%, or 3.0% a year.

Next: where the numbers come from
Where the numbers come from

Read from 6 registered funds that hold it

A hedge fund reports almost nothing about itself. Others report about it, and that is what we read.

Registered funds that hold PFM Healthcare Master Fund

Mutual funds and interval funds report every holding to the SEC on Form N-PORT. When one of them owns a stake in a hedge fund, its filings show what that stake was worth on each date.

HolderListed asReportsSeenLatest value held
A&Q Technology Fund LLCPFM HEALTHCARE FUND1630 Sep 2022 to 30 Jun 2026USD 15m
AB Multi-Manager Alternative FundPFM HEALTHCARE OFFSHORE FUND LTD D CYTRELLIS BIOSYSTEMS B 1 ABMMALT1431 Mar 2023 to 30 Jun 2026USD 1,876
AB Multi-Manager Alternative FundPFM HEALTHCARE OFFSHORE FUND LTD CLASS A 10 MMAF1431 Mar 2023 to 30 Jun 2026USD 1,629
AB Multi-Manager Alternative FundPFM HEALTHCARE OFFSHORE FUND LTD AURIS SURGICAL ROBOTICS SIDE POCKET D1 1 ABMMAF331 Mar 2023 to 30 Sep 2023USD 0
AB Multi-Manager Alternative FundPFM HEALTHCARE OFFSHORE FUND LTD AURIS SURGICA931 Dec 2020 to 31 Dec 2022USD 0
AB Multi-Manager Alternative FundPFM HEALTHCARE OFFSHORE FUND LTD D CYTRELLIS B931 Dec 2020 to 31 Dec 2022USD 224,000
PFM Health Sciences, LP's disclosed U.S. long book

Every quarter the manager lists its U.S. listed long positions on Form 13F, most recently USD 1.2bn with options counted at the value of the shares they cover for 30 June 2026. Pricing those positions through each year gives the return of the long book alone. It covers all the manager's clients, not this fund, and leaves out shorts, leverage, non-U.S. holdings and fees. The long book is most of what the manager's hedge funds hold, so it says a good deal about this fund.

20212022202320242025
13F long book11.6%-15.3%13.3%-1.2%37.5%
S&P 50028.7%-18.1%26.3%25.0%17.9%
-20%-10%0%10%20%30%40%20212022202320242025
Next: size and investors
Size and investors

USD 2.2bn in gross assets, down from USD 3.7bn reported in 2022

The fund in Form ADV, Schedule D

What the adviser reported about this fund in the filing of 24 June 2024. Gross assets are the fund's total assets before borrowings are deducted. They are not net assets and say nothing about performance.

Gross asset valueUSD 2.2bn
Beneficial owners425
Owned by the adviser and its people15%
Owned by funds of funds38%
Owned by non-U.S. persons13%
Investor eligibility3(c)(7): qualified purchasers
DomicileCayman Islands
StructureMaster fund
Full legal namePFM Healthcare Master Fund, L.P.
SEC private fund ID805-2068226774
Gross assets over timeUSD bn, by the year the figure was filed

Each bar is the gross asset value in that year's Form ADV. An annual filing reports the previous fiscal year end, so each bar describes the year before. A change in gross assets is not a return: money coming in, money going out, borrowing and performance all move it, and the filings do not say which.

20141.620151.120161.520171.620182.520193.120202.720213.020223.720233.120242.2
Master and feeder funds

Investors often enter through a feeder that passes their money to a master fund, where the trading happens.

  • Feeder: PFM Healthcare Fund, L.P.
  • Feeder: PFM Healthcare Offshore Fund, Ltd.
Next: who audits and administers it
Service providers

Audited by KPMG LLP, administered by Hedgeserv (Cayman)

An outside auditor and an administrator that is not part of the manager are the two checks an investor can verify from public filings.

Named by the adviser in Form ADV Schedule D, questions 23 to 28, in the filing of 24 June 2024.

RoleFirmWhereAs stated in the filing
AuditorKPMG LLPSan Francisco, CaliforniaIndependent, pcaob registered
AdministratorHedgeserv (Cayman) Ltd.Grand Cayman, Cayman IslandsNot related to the adviser
Prime brokerMerrill Lynch Professional Clearing Corp.New York, New YorkAlso custodian
Prime brokerJ.P. Morgan Securities LLCNew York, New YorkAlso custodian
Prime brokerGoldman Sachs & Co. LLCNew York, New YorkAlso custodian
Prime brokerMorgan Stanley & Co. LLCNew York, New YorkAlso custodian
CustodianJPMorgan Chase Bank, N.A.New York, New YorkNot related to the adviser
CustodianMorgan Stanley & Co. LLCNew York, New YorkNot related to the adviser
CustodianFirst Republic BankSan Francisco, CaliforniaNot related to the adviser
CustodianMerrill Lynch Professional Clearing Corp.New York, New YorkNot related to the adviser
CustodianJ.P. Morgan Securities LLCNew York, New YorkNot related to the adviser
CustodianGoldman Sachs & Co. LLCNew York, New YorkNot related to the adviser
MarketerJ.P. Morgan Securities LLCNew York, New YorkNot related to the adviser
MarketerMorgan StanleyNew York, New YorkNot related to the adviser
Audit and valuation
Audited every yearYes
Statements under U.S. GAAPYes
Audited statements sent to investorsYes
Share of assets valued by an outside party94%
General partner, manager or directors

Form ADV Schedule D, question 3.

  • Partner Asset Management, LLC
Next: how the fund is offered
The offering, from Form D

Offering filed by a related vehicle

The Form D linked to this fund was filed by PFM Healthcare Fund L P, a related vehicle of the same manager, often the feeder or offshore twin through which investors come in. The figures below describe that vehicle.

Issuer on the filingPFM Healthcare Fund L P
Total sold to dateUSD 1.8bn
Investors to date573
Date of first sale1 January 2006
Exemptions claimed06b, 3C, 3C.7
EntityLimited Partnership
JurisdictionDelaware
Form D filings on EDGAR20
Next: the manager
The manager

PFM Health Sciences runs 3 funds we cover

AdviserPFM Health Sciences, LP
StatusSEC-registered adviser
Registered since10 April 2008
SEC number801-69012
CRD number146747
OfficeSan Francisco, CA
Latest Form ADV31 March 2026
Brochure (Part 2A)31 March 2026
In the manager's own words

What PFM Health Sciences, LP says about itself on pfmhealthsciences.com, read on 14 November 2026. A sentence in quotation marks is the firm's own; the rest is in our words. These are the firm's statements, not ours, and we have not checked them. They describe the firm as a whole, not this fund.

“Founded in 2004, PFM Health Sciences is a leading healthcare investment advisor currently managing approximately $2 billion in public and private investments.”

What it says it doesHealthcare and biotechnology
Offices it listsSan Francisco
People namedBrian Grossman, Managing Partner, CIO, Portfolio Manager
On the siteA team page and an investor login
The manager at a glance

Gross assets are added across the funds we cover and count a master fund and its feeders separately, so they overstate the money the firm runs.

Funds of this manager on PPLI.com3
Their gross assets togetherUSD 2.3bn
With return figures3
U.S. long book on Form 13FUSD 1.2bn
Positions in that book98
Form ADV filings that list this fund39
The paper trail

Dates taken from the filings themselves.

  • 10 Apr 2008 PFM Health Sciences, LP registered with the SEC
  • 1 Apr 2013 First Form ADV in the SEC's bulk data to list the fund
  • 31 Dec 2020 First appears as a holding of a registered fund
  • 24 Jun 2024 Latest Form ADV listing the fund in the bulk data
  • 31 Mar 2026 Latest Form ADV of the manager
  • 14 Aug 2026 Latest Form 13F of the manager, for 30 June 2026
  • 13 Oct 2026 Latest Form D of the related vehicle
Next: holding it inside a policy
Inside a policy

Can PFM Healthcare Master Fund be held inside a PPLI policy?

Not directly, for a U.S. taxpayer. U.S. tax rules test what a policy holds for diversification, and a fund that is also sold to investors outside insurance accounts counts as a single holding and is not looked through to what it owns. Choosing such a fund yourself also raises the investor-control question the IRS has ruled on.

In practice a U.S.-compliant policy reaches a hedge fund strategy through an insurance-dedicated fund, whose interests are held by insurers' separate accounts with a few exceptions the regulations allow, or through a separately managed account run for the insurer. Policies issued outside the United States for people who are not U.S. taxpayers follow the rules of their own jurisdiction, and those differ.

Some managers run an insurance-dedicated version of their strategy. Where they do, gains that a taxable investor would pay tax on each year can build up inside the policy, as long as the policy keeps to the rules. We have no record that PFM Health Sciences, LP offers one. That is a gap in our file, not a finding that it does not. We keep a directory of insurance-dedicated funds and the managers behind them.

Insurance-dedicated funds on PPLI.com   Hedge fund strategies inside PPLI

The diversification test, on the manager's reported book

The investments inside a policy must be spread: no more than 55% in one holding, 70% in two, 80% in three and 90% in four. This table runs that test on the positions PFM Health Sciences, LP reported on Form 13F for 30 June 2026. It is a rough guide only, since an insurance-dedicated version would hold the whole strategy, shorts included.

MeasureLimitThis bookResult
The largest holding55%5%Within the limit
The two largest70%10%Within the limit
The three largest80%14%Within the limit
The four largest90%17%Within the limit

On this evidence the long book is spread widely enough.

Next: notes on this file
Notes

What the filings leave open

What we would ask the manager

Questions the filings raise and cannot answer.

  • 94% of the assets are valued by an outside party. Who values the rest, and how often is that tested?
  • Reported gross assets have fallen from USD 3.7bn to USD 2.2bn. How much of that was performance and how much was investors leaving?
  • Do you offer this strategy as an insurance-dedicated fund or a separately managed account for insurers?
Changes to this file
  • 13 Nov 2026 File opened from SEC filings
  • 14 Nov 2026 Manager's website read and its facts added
  • 15 Nov 2026 Page revised.
The manager's response

Not yet received. PFM Health Sciences, LP can ask us to check any fact on this page and can send a response, which we will publish here unedited. Write to the editor.

Next: questions
Questions

Questions about PFM Healthcare Master Fund

What has PFM Healthcare Master Fund returned?

The SEC filings of PFM Healthcare Master Fund carry no return figures. PPLI Vortex estimates, from SEC filings: 11.4% in 2023, -15.5% in 2024, 16.0% in 2025, 11.4% in 2026 to 30 Jun. Each estimate has a range; for 2025 it is 3.4% to 38.6%.

How reliable are the return figures for PFM Healthcare Master Fund?

They are estimates, not figures reported by the fund. Each one is shown with a range and a grade. The grade for the latest figure is D-est: estimated from one public holder's reported value. Shorts, leverage, trading within a quarter and fees are not visible in public filings.

What does PFM Healthcare Master Fund invest in?

PFM Healthcare Master Fund does not publish its holdings. Its manager, PFM Health Sciences, LP, reported 98 U.S.-listed positions worth USD 1.2bn on Form 13F for 30 June 2026. The largest were Ascendis Pharma A/S, Axsome Therapeutics, Inc., ELI LILLY & Co. The filing covers all of the manager's accounts and excludes short positions.

How big is PFM Healthcare Master Fund?

PFM Healthcare Master Fund reported gross assets of USD 2.2bn in the Form ADV filed 24 June 2024. Gross assets are total assets before borrowings are deducted, so the figure is larger than what investors have put in when the fund uses leverage.

Who audits and administers PFM Healthcare Master Fund?

The auditor is KPMG LLP. The administrator is Hedgeserv (Cayman) Ltd. These are the firms named in the Form ADV filed 24 June 2024.

Who runs PFM Health Sciences, LP?

On its own website PFM Health Sciences, LP names Brian Grossman (Managing Partner, CIO, Portfolio Manager). That is the list the firm gave when we read the site on 14 November 2026, and people move, so check with the firm.

What does PFM Health Sciences, LP invest in?

On its website the firm writes mainly about healthcare and biotechnology. That is how it describes itself, and it covers the whole firm, not PFM Healthcare Master Fund alone.

Where is PFM Health Sciences, LP based?

Its website lists San Francisco. The address on its SEC filing is in the manager section above.

Who manages PFM Healthcare Master Fund?

PFM Health Sciences, LP, CRD number 146747. It is an SEC-registered adviser.

Can PFM Healthcare Master Fund be held inside a PPLI policy?

Not directly, for a U.S. taxpayer. Under U.S. tax rules a policy reaches a hedge fund strategy through an insurance-dedicated fund or a separately managed account run for the insurer, not through a fund that is also sold to other investors. Policies issued outside the United States follow their own rules. We have no record that PFM Health Sciences, LP offers an insurance-dedicated version, so an investor would need to ask the firm.

What did PFM Healthcare Master Fund return each quarter?

PFM Healthcare Master Fund does not file quarterly returns with the SEC. PPLI Vortex estimates 3.0% in the third quarter of 2025, 5.9% in the fourth quarter of 2025, 0.0% in the first quarter of 2026 and 13.0% in the second quarter of 2026. Each figure has a range, shown on the page.

Next: how we work
Method and sources

How this page was put together

The return figures on this page come from PPLI Vortex, the engine we built to work out hedge fund returns from SEC filings. For this fund it reads Form N-PORT, in which registered funds report the value of every holding, including their stakes in private funds. The change in the reported value of a stake between two dates, adjusted for money added or withdrawn where the filings show it, gives the return. Fund facts come from Form ADV Schedule D, section 7.B.(1), and from Form D. Apart from the short passage taken from the manager's public website and marked as such, nothing here comes from the fund or its manager.

Form ADV usedFiled 24 June 2024
Form D used13 October 2026
Public holder reports to30 June 2026
13F quarter30 June 2026
EnginePPLI Vortex v12.4
CorrectionsWrite to the editor

The full methodology

For the fund and its manager

Do you run PFM Healthcare Master Fund? Help us get it right.

If you manage this fund or work for PFM Health Sciences, LP, you can correct a fact, send us figures we do not have, such as audited returns, fees and terms, or point out a mistake. So can anyone else who spots one.

[email protected]

Please give the fund's name and its SEC private fund ID, 805-2068226774. We check what we receive against the filings, mark on the page what came from the manager, and publish any response you send, unedited.

Important information

Return figures on this page are estimates computed by PPLI.com from public regulatory filings using its PPLI Vortex engine. They are not reported, confirmed or audited by the fund, each is shown with a range and a confidence grade, and the true figures may differ materially from what investors received.

PPLI.com has no relationship with PFM Healthcare Master Fund or PFM Health Sciences, LP, and neither has reviewed or approved this page. Facts are taken from filings with the U.S. Securities and Exchange Commission as of the dates shown and may since have changed. Holdings come from the manager's Form 13F, which covers all of its accounts and omits short positions, so they are not a statement of what this fund owns.

Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy an interest in any fund or insurance policy. Interests in private funds are offered only to eligible investors, by the fund's own offering documents. Past performance, estimated or reported, does not predict future results. The calculators are illustrations built on assumptions you can change. To report an error, write to the editor.

Full legal name PFM Healthcare Master Fund, L.P.SEC private fund ID 805-2068226774Updated 15 November 2026
Private consultation →
Step 1 of 2

Tell us about yourself

Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.

✦Research assistant
✦PPLI.comResearch assistant
Explore PPLI questions and suitability factors
Ask a general question about PPLI, or explore the factors that affect suitability. Treat the answer as a starting point and check the linked sources.
Use the research with your own tax, legal and insurance advisers.
Preparing an answer
AI assistant. Educational information only. It does not determine eligibility or provide personal tax, legal, investment or insurance advice.